Creative Biosciences
company
About
Creative Biosciences is a biomedical technology company.
- 51 - 100
Details
- Last Funding Type
- Series D
- Last Funding Money Raised
- ¥560M
- Industries
- Biopharma,Biotechnology,Health Care
- Founded date
- Jan 1, 2015
- Number Of Employee
- 51 - 100
- Operating Status
- Active
Kang Liming Bio is a biomedical technology company that specializes in the development, production and sales of tumor screening diagnostic products such as colorectal cancer fecal non-invasive screening kits.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
2
¥1.16B
Creative Biosciences has raised a total of
¥1.16B
in funding over 2 rounds. Their latest funding was raised on
Oct 14, 2021 from a Series D round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Oct 14, 2021 | Series D | ¥560M | 1 | — | — | Detail |
| Sep 27, 2020 | Series C | ¥600M | 3 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
4
Creative Biosciences is funded by 4 investors.
Agricultural Bank of China
and Shengyu Touzi
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Agricultural Bank of China
|
— | Series D |
|
|
— | Series C |
Innovitalize Capital
|
— | Series C |
|
|
— | Series C |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
